Literature DB >> 10379443

Thermoplastic polyurethane--the material used for the Erlanger silver catheter.

T Hentschel1, H Münstedt.   

Abstract

The Erlanger silver catheter consists of a thermoplastic polyurethane elastomer (TPU). To achieve an antimicrobial effect, silver particles at a concentration of 0.5-1.0% by weight are incorporated into the basic material. The good mechanical properties were shown to remain present after the incorporation of the silver. The characteristic mechanical data of blends made of a soft and a hard TPU type approximated closely to a linear relationship with the ratio of the mixture. The buckling stability of catheters as a function of their cross section could be described by Euler's formula. This enables the buckling stability to be calculated when material constants and catheter geometry are known.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10379443     DOI: 10.1007/bf02561617

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  3 in total

1.  Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter.

Authors:  M Böswald; S Lugauer; A Regenfus; G G Braun; P Martus; C Geis; J Scharf; T Bechert; J Greil; J P Guggenbichler
Journal:  Infection       Date:  1999       Impact factor: 3.553

2.  Characterization of thermoplastic polyurethane/polylactic acid (TPU/PLA) tissue engineering scaffolds fabricated by microcellular injection molding.

Authors:  Hao-Yang Mi; Max R Salick; Xin Jing; Brianna R Jacques; Wendy C Crone; Xiang-Fang Peng; Lih-Sheng Turng
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2013-08-02       Impact factor: 7.328

3.  Nano-silver-incorporated biomimetic polydopamine coating on a thermoplastic polyurethane porous nanocomposite as an efficient antibacterial wound dressing.

Authors:  Menglong Liu; Tengfei Liu; Xiwei Chen; Jiacai Yang; Jun Deng; Weifeng He; Xiaorong Zhang; Qiang Lei; Xiaohong Hu; Gaoxing Luo; Jun Wu
Journal:  J Nanobiotechnology       Date:  2018-11-12       Impact factor: 10.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.